Diamyd Medical’s associated company Cellaviva launches service for private family saving of stem cells

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today that the Company’s associated company Cellaviva AB on September 1 launches its service in which expecting parents in Sweden can save stem cells from their newborn child.

[Read the full article here]

Comments are closed.